Great Britain is purchasing 30 million doses of the Coronavirus vaccine developed by the University of Oxford in collaboration with the Italian Advent-IRBM, based in Pomezia (Rome). “The product development is really positive at present. The time has been unbelievably shortened and there is a good chance to have a significant number of doses within the end of September, when we will find out if the vaccine candidate will become a vaccine”, explains Di Lorenzo, President and CEO of IRBM.
Article published on Il Messaggero – 18/05/2020
Read the original article on ilmessaggero.it